Next Article in Journal
Transcriptional Response to Hypoxia: The Role of HIF-1-Associated Co-Regulators
Next Article in Special Issue
Cellular Functions of High-Temperature Requirement Factor A4 in Placenta
Previous Article in Journal
No Time to Die—How Islets Meet Their Demise in Transplantation
Previous Article in Special Issue
Cross-Generational Impact of Innate Immune Memory Following Pregnancy Complications
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Cells
Volume 12
Issue 5
10.3390/cells12050797
cells-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Maternal and Intrauterine Influences on Feto-Placental Growth Are Accompanied by Sexually Dimorphic Changes in Placental Mitochondrial Respiration, and Metabolic Signalling Pathways

by
Esteban Salazar-Petres
1,†,
Daniela Pereira-Carvalho
2,†,
Jorge Lopez-Tello
2,*,‡ and
Amanda N. Sferruzzi-Perri
2,*,‡
1
Departamento de Ciencias Básicas, Facultad de Ciencias, Universidad Santo Tomás, Valdivia 5090000, Chile
2
Centre for Trophoblast Research, Department of Physiology, Development and Neuroscience, University of Cambridge, Cambridge CB2 3EG, UK
*
Authors to whom correspondence should be addressed.
†
These authors contributed equally to this work.
‡
These authors contributed equally to this work.
Cells 2023, 12(5), 797; https://doi.org/10.3390/cells12050797
Submission received: 30 January 2023 / Revised: 26 February 2023 / Accepted: 1 March 2023 / Published: 3 March 2023
(This article belongs to the Special Issue Signaling Pathways in Pregnancy)
Browse Figures
Review Reports Versions Notes

Abstract

:
Adverse maternal environments such as small size, malnutrition, and metabolic conditions are known to influence fetal growth outcomes. Similarly, fetal growth and metabolic alterations may alter the intrauterine environment and affect all fetuses in multiple gestation/litter-bearing species. The placenta is the site of convergence between signals derived from the mother and the developing fetus/es. Its functions are fuelled by energy generated by mitochondrial oxidative phosphorylation (OXPHOS). The aim of this study was to delineate the role of an altered maternal and/or fetal/intrauterine environment in feto-placental growth and placental mitochondrial energetic capacity. To address this, in mice, we used disruptions of the gene encoding phosphoinositol 3-kinase (PI3K) p110α, a growth and metabolic regulator to perturb the maternal and/or fetal/intrauterine environment and study the impact on wildtype conceptuses. We found that feto-placental growth was modified by a perturbed maternal and intrauterine environment, and effects were most evident for wildtype males compared to females. However, placental mitochondrial complex I+II OXPHOS and total electron transport system (ETS) capacity were similarly reduced for both fetal sexes, yet reserve capacity was additionally decreased in males in response to the maternal and intrauterine perturbations. These were also sex-dependent differences in the placental abundance of mitochondrial-related proteins (e.g., citrate synthase and ETS complexes), and activity of growth/metabolic signalling pathways (AKT and MAPK) with maternal and intrauterine alterations. Our findings thus identify that the mother and the intrauterine environment provided by littermates modulate feto-placental growth, placental bioenergetics, and metabolic signalling in a manner dependent on fetal sex. This may have relevance for understanding the pathways leading to reduced fetal growth, particularly in the context of suboptimal maternal environments and multiple gestation/litter-bearing species.

1. Introduction

To meet fetal growth requirements, the placenta adapts and changes functionally under normal and altered intrauterine environments [1,2,3,4,5,6]. These changes are fundamental to maintain fetal growth trajectory and development and are aided by the endocrine output from the placenta that encourage physiological changes in the mother and ensure nutrients are available for transfer to the fetus [7,8,9,10]. From the perspective of the placenta, the intrauterine environment is a site of convergence between signals derived from the mother and those from the developing fetus or fetuses in the case of multiple gestation/litter-bearing species [3,11,12]. Mouse and human placentas are relatively similar in exchange, endocrine function, and morphology, as both are haemochorial in nature. However, the murine placenta is divided in two distinguished regions: the junctional zone (responsible for endocrine production) and the labyrinth zone (LZ; substrate exchange) [13,14,15], whereas in the human placenta, the villous syncytiotrophoblast performs both functions. Nevertheless, comparative proteomic and transcriptomic analyses of mouse placental LZ and human placental villous samples showed that over 80% of genes implicated in mouse placental phenotypes are co-expressed in both species [16]. Studies performed on mice and humans demonstrate that under unfavourable health conditions, maternal adaptations may fail, leading to abnormal nutrient partitioning and pregnancy complications. Under these adverse conditions, placental development may also be compromised, yet, in certain situations, the placenta may also be capable of maintaining or even increasing nutrient supply to optimize fetal growth in that prevailing environment [17,18,19,20,21,22,23]. However, further work is required to understand the role of maternal and fetal signals in conditioning the intrauterine environment and to uncover the cellular and molecular pathways that may modulate placental metabolic functions [24].
Adaptations in placental transport capacity could be related to changes in mitochondrial function. This is because the placenta relies heavily on energy (ATP) that is generated primarily by mitochondria. Mitochondria generate ATP via oxidative phosphorylation (OXPHOS) and reducing substrates derived from β-oxidation and the tricarboxylic acid cycle [25]. The energy generated by mitochondria is used for placental metabolism, growth, morphological remodelling, and to actively transport a range of substrates from the mother to the fetus for growth and development [26,27,28,29,30]. Prior work has reported that placental mitochondrial bioenergetic capacity alters developmentally to meet the increasing fetal demands for growth toward term in humans and animal models [31,32]. Moreover, there are changes in placental mitochondrial function in human pregnancies and rodents exposed to unfavourable maternal environments, which includes changes in OXPHOS and mitochondrial-related proteins [31,33,34,35,36,37,38,39]. Finally, accumulating findings are demonstrating that placental adaptive responses, and mitochondrial function specifically, are different for female and male fetuses [1,26,39,40,41]. However, it remains unclear how the maternal and intrauterine environments interact to modulate placental mitochondrial function and, consequently, how this interaction relates to the placental support of female and male fetal growth.
To address these key deficiencies in knowledge, this study used disruptions of the gene encoding phosphoinositol 3-kinase (PI3K) p110α (Pik3ca) in mice as a tool to perturb the intrauterine environment and assess the impact on feto-placental development, placental mitochondrial respiration, and metabolic signalling pathways of female and male wildtype fetuses. The PI3K signalling pathway is a critical signalling pathway that regulates cell metabolism and growth [42,43,44,45,46,47,48]. Moreover, this pathway mediates the metabolic effects of insulin [49,50,51] by promoting glucose uptake and glycogen synthesis [52,53]. This is highly relevant since previous work has found that PI3K-p110α signalling is required for mediating metabolic adaptations in the mother that support fetal glucose transfer during pregnancy [24,54,55]. Other work has also shown that PI3K-p110α signalling regulates placental LZ formation [21,56]. Finally, PI3K-p110α signalling deficiency in the fetus causes growth stunting and mal-formed placentas of both males and females, and the presence of PI3K-p110α mutants would be expected to influence the intrauterine environment and, hence, the development of wildtype siblings [21,24,56].

2. Materials and Methods

2.1. Animals and Experimental Design

Mice were housed at the University of Cambridge Animal Facility and the study was undertaken abiding by the UK Home Office Animals (Scientific Procedures) Act 1986 after approval from the University of Cambridge ethics committee (UK HOL PP6324596). Mice were allowed to drink and feed ad libitum and were housed under a 12:12 h light-dark cycle. This study employed wildtype (WT) mice and mice with partial inactivation of the PI3K isoform p110α, which was induced via heterozygous inheritance of a dominant negative mutation in Pik3ca (Pik3ca-D933A; mice are defined as α/+ in the text). The generation of the α/+ mutant mice has previously been reported [49] and they have been on a C57BL/6 background for more than 10 generations. Female mice were virgin and aged 4-months when they were mated with males. Three types of crosses of mice were generated in this study (Figure 1). Briefly, WT females were mated with WT males (WT x WT) to generate pregnancies with control WT litters. WT females were mated with α/+ males (WT x α/+) to generate pregnancies with litters containing α/+ conceptuses (adverse intrauterine environment). Finally, α/+ females were mated with WT males (α/+ x WT) to generate pregnancies with litters containing α/+ conceptuses within a mother who was α/+ (adverse intrauterine and maternal environment) [24,54]. The detection of a mating plug in the female vagina was used to indicate gestational day 1 (Gd1).

2.2. Tissue Collection and Genotyping

Pregnant dams were killed by cervical dislocation on Gd18 for retrieval of the gravid uterus. Fetuses and placentas were dissected free of fetal membranes and individually weighed. After weighing the placenta, the placental labyrinth LZ was micro-dissected from the endocrine junctional zone. The LZ was then weighed and either immediately snap frozen or placed in cryopreservation media prior to snap freezing (0.21 M mannitol, 0.07 M sucrose, 30% DMSO, pH 7.5). These LZ samples were stored at −80 °C for subsequent molecular and mitochondrial respiratory analyses, respectively. Fetal tails were taken to determine sex (Sry gene F: 5′-GTGGGTTCCTGTCCCACTGC-3′, R: 5′-GGCCATGTCAAGCGCCCCAT-3′ and autosomal PCR control gene F: 5′-TGGTTGGCATTTTATCCCTAGAAC-3′, R: 5′-GCAACATGGCAACTGGAAACA-3′) and α/+ genotype (F: 5′-TTCAAGCACTGTTTCAGCT-3′ and R: 5′-TTATGTTCTTGCTCAAGTCCTA-3′) [55]. Only WT conceptuses were analysed in this study.

2.3. Placental LZ Mitochondrial Respirometry

Mitochondrial respiratory capacity was examined in placental LZ samples using high resolution respirometry (Oxygraph 2k respirometer; Oroboros Instruments, Innsbruck, Austria), using a sequential substrate, inhibitor, uncoupler titration (SUIT) protocol as reported previously [1]. In brief, thawed LZ samples (in sucrose solution, pH 7.5) were permeabilized using saponin (5 mg/ mL, Sigma-Aldrich, Gillingham, UK) in biopsy preservation medium (BIOPS; pH 7.1, containing 10 mM Ca-EGTA buffer, 0.1µM free Ca2+, 1 mM free Mg2+, 20 mM imidazole, 20 mM taurine, 50 mM K-MES, 0.5 mM DTT, 6.56 mM MgCl2, 5.77 mM ATP, and 15 mM phosphocreatine). Following washes in respiratory medium (MiR05; pH 7.1 solution containing 20 mM HEPES, 0.46 mM EGTA, 2.1 mM free Mg2+, 90 mM K+, 10 mM Pi, 20 mM taurine, 110 mM sucrose, 60 mM lactobionate, and 1 g/L BSA), 15–20 mg of LZ sample was analysed at 37 °C in a pre-calibrated Oxygraph-2k respirometer chamber. Oxygen concentration was kept between 250 μM and 300 μM, and real-time acquisition and assessment of oxygen consumption was obtained using the SUIT protocol [1] and DatLab software (V7, Oroboros Instruments). To provide information about outer membrane integrity, exogenous cytochrome c (10 µM) was added during maximum OXPHOS capacity (after succinate addition to activate CI and CII pathways in the presence of ADP), and LZ samples showing a >30% increase in oxygen consumption were excluded (a total of 6 placentas from different groups were excluded from the study), as suggested by others [57]. Respiration was expressed as oxygen consumption per mg of placental LZ tissue.

2.4. Western Blot Analysis

Protein abundance was determined in placental LZ samples (representative for each sex and genotype) using Western blotting as previously described [1]. Briefly, proteins were extracted using RIPA buffer (Thermo Fisher Scientific, Waltham, MA, USA) supplemented with Mini EDTA-free protease inhibitor cocktail mix (Roche, Basel, Switzerland, CH). Proteins were separated using electrophoresis and transferred onto 0.2 μm nitrocellulose membranes (Bio-Rad Laboratories, Hercules, CA, USA). Membranes were blocked in tris-buffered saline with Tween 20 (TBS-T) plus 5% milk or fetal bovine serum for one hour at room temperature and subsequently incubated overnight with primary antibodies described in Supplementary Table S1. The day after, membranes were washed in TBS-T and incubated with secondary antibodies (NA934 or NA931; 1:10,000). Protein bands were visualized via enhanced chemiluminescence using SuperSignal™ West Femto Substrate (Thermo Fisher Scientific, MA, USA). Signal intensity was determined using ImageJ, version 2.1.0 software, and proteins were normalized to protein loading as informed by Ponceau S staining [58].

2.5. Statistical Analysis

Statistical analyses were performed using GraphPad Prism version 9 (GraphPad, CA, USA). Outliers were detected by the Prisms Grubbs’ test. To analyse the effect of the mating cross (WT x WT, WT x α/+, and α/+ x WT) on WT conceptus development and LZ mitochondrial respirometry, each sex was analysed separately by one-way ANOVA followed by Tukey post hoc tests. Litter composition (sex and α/+ genotype) was analysed using Chi-squared analysis. Data are shown as mean ± SEM with individual datapoints. Data were considered statistically significant at values of p < 0.05. Any tendency for a significant effect (p < 0.07) are stated with specific p value in the text.

3. Results

3.1. Littermate and/or Maternal p110α Deficiency Alters Feto-Placental Growth of WT Fetuses in a Sex-Specific Manner

We used our three parental crosses (female x male: WT x WT, WT x α/+, and α/+ x WT, shown in Figure 1) to assess if littermate and/or maternal p110α deficiency affects the growth of WT conceptuses. In particular, by comparing to WT x WT, pregnancies generated by the WT x α/+ cross informed on the impact of adverse intrauterine conditions (presence of α/+ littermates in utero), whilst those created by mating α/+ females with WT mates informed on the combined effect of an adverse intrauterine and an adverse maternal environment [24,54]. Comparing WT x α/+ and α/+ x WT pregnancies allowed us to deduce the influence of an adverse maternal environment due to α/+ deficiency on WT conceptus growth. We found there was no effect of the parental cross on litter size or sex ratio and there was also no difference in the percentage of α/+ pups within the litter between WT x α/+ and α/+ x WT pregnancies (Supplementary Table S2).
By analysing each fetal sex separately, we found that WT female fetuses from α/+ x WT pregnancies were growth-restricted when compared to those from either the WT x WT or WT x α/+ pregnancies (Figure 2A). Further, WT male fetuses from WT x α/+ pregnancies were significantly heavier when compared to those from the WT x WT and α/+ x WT pregnancies (Figure 2A). Placental weight of WT female fetuses did not vary between WT x WT, WT x α/+, and α/+ x WT pregnancies. In contrast, WT male placental weight was greater in α/+ x WT pregnancies compared to WT x WT and WT x α/+ pregnancies (Figure 2B). Similar to placental weight, no differences were detected in the LZ weight between groups for WT female fetuses, but LZ weight for WT male fetuses in α/+ x WT pregnancies was heavier when compared to WT x WT pregnancies (Figure 2C). Since our study is focused on responses of the placental LZ, which determines nutrient supply to the fetus for growth, we calculated the ratio between fetal weight and placental LZ weight. This calculation revealed that fetal weight as a proportion of LZ weight was not different among the groups in females but was lower in males from the α/+ x WT group when compared to WT x WT and WT x α/+ groups (Figure 2D). Collectively, these findings suggest that littermate and maternal p110α deficiency modifies WT conceptus growth. However, the specific nature of these changes depends on fetal sex.

3.2. Littermate and/or Maternal p110α Deficiency Alters Mitochondrial Bioenergetics in the Placental LZ of WT Fetuses of Both Sexes

To understand how littermate and maternal p110α deficiency modifies WT conceptus growth, we then assessed placental LZ mitochondrial function in WT fetuses from our three pregnancy groups (WT x WT, WT x α/+, and α/+ x WT). While there were no differences in Complex (C) CILEAK and CIOXPHOS in both WT females and males between our different experimental groups (Figure 3A,B), maximal respiratory capacity through CI and II (CI + CIIOXPHOS) was lower in the LZ of both female and male WT fetuses from WT x α/+ and α/+ x WT pregnancies compared to WT x WT pregnancies (Figure 3C). This was related to lower CII-associated oxygen consumption in WTs of both sexes in WT x α/+ and α/+ x WT versus WT x WT pregnancies (Figure 3D). It was also related to a reduction in oxygen consumption by the total ETS for female and male WTs in WT x α/+ and α/+ x WT litters (Figure 3E). Mitochondrial reserve capacity was profoundly decreased in the placental LZ of WT males from WT x α/+ and α/+ x WT pregnancies (∼−60% and ∼−73%, respectively, compared to WT x WT), meanwhile, no differences were detected for WT female fetuses (Figure 3F). There was a greater contribution of CI-associated leak respiration to total ETS capacity in the placental LZ of both sexes in the α/+ x WT group compared to the WT x WT group (Figure 3G). However, in the OXPHOS state, the contribution of CI to total ETS was increased only in the placental LZ of WT females, and not males and this was observed for both the WT x α/+ and α/+ x WT compared to WT x WT pregnancies (Figure 3H). There were no differences in oxygen flux associated with fatty acid oxidation and CIV activity for female or male WT fetuses between the three crosses (Supplementary Figure S1). Taken together, these results indicate that placental LZ mitochondrial bioenergetics of both female and male WT fetuses is modulated by littermate and maternal p110α deficiency.

3.3. Littermate and/or Maternal p110α Deficiency Alters the Expression of Mitochondrial-Related Proteins in the Placental LZ of WT Fetuses in a Sex-Specific Manner

To provide information on the molecular changes mediating alterations in mitochondrial bioenergetics with littermate and maternal p110α deficiency, Western blotting was used to quantify the abundance of individual ETS complexes and additional mitochondrial-related proteins in the placental LZ of WT fetuses in our three pregnancy groups (WT x WT, WT x α/+, and α/+ x WT). There was a decreased abundance of CI and CII proteins in the placental LZ of WT females in both WT x α/+ and α/+ x WT pregnancies, compared to WT x WT (Figure 4A). In WT males, CI was instead significantly increased in both WT x α/+ and α/+ x WT pregnancies compared to WT x WT pregnancies and no difference in CII levels between the three pregnancy groups was found (Figure 4B). There was an increased abundance of CIII protein in WT females from the WT x α/+ compared to the WT x WT group, but again, no changes were seen in males (Figure 4A,B). CIV protein expression was decreased in the LZ of both WT female and male fetuses from α/+ x WT pregnancies when compared to WT x α/+. No differences were detected in CV protein abundance between the three groups regardless of fetal sex (Figure 4A,B).
The abundance of citrate synthase, an indicator of mitochondrial density, and the abundance of PGC-1α, a transcription factor that promotes mitochondrial biogenesis, were altered in the LZ of male but not female WT fetuses, presenting with an increase for both proteins in WT x α/+ and α/+ x WT pregnancies, compared to WT x WT (Figure 4C,D). In contrast, the abundance of PPARγ, another transcription factor that regulates mitochondrial biogenesis, was reduced in the placental LZ of WT female fetuses of WT x α/+ pregnancies when compared with WT x WT, whilst no differences were observed for males (Figure 4E). Finally, we evaluated the abundance of UCP2, a protein that uncouples oxygen consumption from ATP synthesis, and found UCP2 was increased in the placental LZ of males, but not females, from WT x α/+ pregnancies, when compared to WT x WT (Figure 4F). Taken together, these data indicate that there are sex-dependent changes in the LZ abundance of key mitochondrial regulatory proteins in WT fetuses exposed to littermate and/or maternal p110α deficiency.

3.4. Littermate and/or Maternal p110α Deficiency Alters the Abundance of Key Growth and Metabolic Signalling Proteins in a Manner That Depends on Fetal Sex

To further understand the mechanisms underlying the sex-specific changes in placental LZ profile in WT fetuses exposed to littermate and maternal p110α deficiency, we evaluated the expression of key growth and metabolic signalling proteins in our three pregnancy groups (WT x WT, WT x α/+, and α/+ x WT: Figure 5A,B). The selected proteins are known to regulate cellular bioenergetics by linking endocrine signals with mitochondrial function [1]. In WT female fetuses, the LZ abundance of total AKT was not affected, but the level of active phosphorylated AKT was decreased in both WT x α/+ and α/+ x WT pregnancies compared to WT x WT (Figure 5C,D). Meanwhile, WT males showed an increased abundance of total AKT in addition to reduced AKT activation only in α/+ x WT pregnancies compared to WT x WT and/or WT x α/+ (Figure 5C,D). WT females in α/+ x WT pregnancies exhibited increased total MAPK 44/42 abundance compared to those from WT x WT and WT x α/+ pregnancies, but no change was seen in the level of active phosphorylated protein. Furthermore, no changes in total or activated MAPK 44/42 were seen for the placental LZ of WT males, with similar values observed for all three pregnancy groups. Total p38 MAPK was also greater in the placental LZ of WT females from α/+ x WT pregnancies, but phosphorylated active levels were reduced in both WT x α/+ and α/+ x WT pregnancies compared to WT x WT. In contrast, in males, only changes in p38 MAPK were observed between the WT x α/+ and α/+ x WT pregnancy groups, with a tendency for increased total p38 MAPK, and a significant decrease in activated p38 MAPK. Together, these data suggest that growth and metabolic signalling proteins in the WT placenta are affected by both littermate and maternal p110α deficiency. Moreover, the nature of these effects depends on fetal sex.

4. Discussion

Using genetic disruption of p110α signalling as a tool, we demonstrated the important influence of the maternal and intrauterine environments on feto-placental growth and placental mitochondrial respiration/metabolism. Specifically, by comparing to pregnancies where both the mother and all fetuses are WT, placental LZ respiratory capacity of WT fetuses of both sexes varied when either littermates and/or the mother was p110α deficient. Moreover, there were alterations in placental LZ mitochondrial bioenergetic capacity that were associated with sex-specific changes in the abundance of mitochondrial-related, growth, and metabolic proteins in the placenta of WTs exposed to littermate and/or maternal p110α deficiency. Together, these data may have relevance for understanding divergent fetal outcomes in pregnancies associated with different gestational conditions. They also support the concept of developing treatments that are targeted to the placenta, which are tailored to the sex of the fetus.
In previous studies done by our laboratory, we demonstrated that conceptus p110α deficiency leads to reduced fetal and placental growth [21,24,56]. Furthermore, α/+ dams have metabolic imbalances before and during pregnancy, which may relate to the altered fetal outcomes observed in this study and in our previous work [24,54,56]. In particular, compared to WT mothers carrying only WT fetuses in the litter, α/+ dams are lighter and unable to shift their glucose handling during pregnancy to favour fetal growth [54]. The novelty of the current work is the finding that WT males in a WT mother who carried α/+ fetuses (WT x α/+) are heavier than those from WT-only pregnancies (WT x WT). Moreover, this effect is lost if the pregnancy was carried by a mutant α/+ dam (α/+ x WT). These data are consistent with other work showing the important influence of genetically altered littermates on the intrauterine growth of their siblings [21,59]. This study therefore extends those findings to show that the influence of an altered intrauterine environment caused by sharing a litter with a mutant fetus (in this case α/+ fetus), is dependent on fetal sex. It is well established that males grow faster than females in utero [1,60,61,62,63]. In addition, recent data indicate that males are more growth-impaired than females in response to fetal p110α deficiency [56]. Therefore, one interpretation may be that WT males can grow more when there is less competition for maternally-supplied metabolic substrates from α/+ littermates. However, this innate ability of WT males to enhance their growth is hindered when the maternal ability to support the pregnancy is compromised by p110α deficiency.
We also found that mitochondrial oxygen consumption in the placental LZ of WT fetuses is responsive to the environment provided by the mother and/or littermates carrying the α/+ mutation. Overall, changes in LZ mitochondrial OXPHOS capacity for WT fetuses was similar for those gestated with p110α deficient littermates (WT x α/+) and/or p110α deficient mother (α/+ x WT), compared to WTs from entire WT pregnancies (WT x WT). This indicates that littermate, and largely not maternal, p110α deficiency impacts mitochondrial respiratory capacity in the placental LZ of WT fetuses. For instance, placental LZ CIIOXPHOS and total ETS were greater for WT fetuses from either WT x α/+ or α/+ x WT pregnancies compared to WT x WT. However, the effect of p110α deficiency to increase LZ CILeak flux control ratio (CILeak/total ETS) was only significant for WT fetuses from α/+ x WT pregnancies compared to WT x WT (values for WT x α/+ pregnancies were intermediate between the two groups). Moreover, some sex-specific changes were found in the effect of littermate p110α deficiency. In particular, LZ CIOXPHOS flux control (CIOXPHOS/total ETS) ratio was elevated only in WT females, and reserve capacity lower only for WT males, in WT x α/+ and α/+ x WT compared to WT x WT pregnancies. Earlier work has demonstrated that overall, both fetal and maternal p110α deficiency results in defective placental endocrine output, namely altered expression of placental lactogen genes [24]. Other work has also reported sex-dependent differences in placental capacity to produce placental lactogens, as well as sex steroids in response to genetic manipulations [64,65]. Placental hormones can exert local effects with resultant impacts on the placental support of fetal development [65,66]. Hence, changes in placental endocrine output may modulate feto-placental phenotype, including mitochondrial respiration of WT littermates, and how this may be modified by fetal sex requires further work. Female and male fetuses also vary in their circulating hormones [67,68], and this could serve as an additional mechanism behind sexually-dimorphic placental mitochondrial phenotypes as reported in several gestational pathologies [69,70,71,72,73,74,75].
Sex-specific differences in WT fetuses exposed to littermate and/or maternal p110α deficiency were related to molecular changes in the placental LZ. For instance, WT females presented a decreased CI and CII protein abundance in both WT x α/+ and α/+ x WT pregnancies, which may explain their reduced mitochondrial respiratory capacity. However, CIII abundance was also up-regulated for WT females from the WT x α/+ parental cross. In contrast, abundance of CI was elevated in the LZ of WT males of both WT x α/+ and α/+ x WT pregnancies and no differences were found for CII or CIII mitochondrial complexes, which could explain the changes in mitochondrial OXPHOS regardless of the parental cross. Interestingly, CIV was similarly affected in both WT females and males, presenting a decreased protein expression only when the mother was p110α deficient (α/+ x WT), when compared to pregnancies generated by a father who was p110α deficient (WT x α/+). Other studies conducted on placentas from adverse maternal gestational environments such as malnutrition, hypoxia, preeclampsia, obesity and metabolic diseases have also reported changes in the abundance of mitochondrial complexes, but few if at all have explored if changes are sex-specific [31,33,37,69,76,77,78,79,80,81,82]. Together these data highlight there is an important role for maternal and intrauterine p110α deficiency in modulating the expression of mitochondrial respiratory complexes by the WT male and female placental LZ.
There were also sex-specific changes in the levels of mitochondria-related proteins in the placental LZ of WT fetuses exposed to littermate and/or maternal p110α deficiency. For instance, abundance of citrate synthase and PGC1α were increased only in WT males from both WT x α/+ and α/+ x WT pregnancies, suggesting a compensatory elevation in mitochondrial density and biogenesis which is in line with higher CI levels compared to WT x WT pregnancies. Additionally, PPAR and uncoupling protein UCP2 protein abundance were altered in WT females and WT males, respectively and only in the group with mutated littermates (WT x α/+). The relevance of these changes though are unknown, especially given that mitochondrial fatty acid oxidation and oxygen consumption in LEAK state were not different for the placental LZ of females or males regardless of the parental cross (no differences between WT x WT, WT x α/+ and α/+ x WT). The abundance and activity of AKT, MAPK 44/42 and p38MAPK signalling proteins in the LZ of WT fetuses were also sex-specifically impacted by littermate and/or maternal p110α deficiency. However, unlike the changes in LZ respiratory capacity and mitochondria-related proteins, the impacts were more pronounced for WT fetuses if the mother plus littermates carried the p110α mutation (the α/+ x WT cross). Compared to both WT x WT and WT x α/+pregnancies, WT females presented increased levels of MAPK 44/42 and p38MAPK, whilst males showed elevated AKT levels. Interestingly, both WT females and males presented decreased levels of activated AKT (phosphorylation/total protein ratio) in α/+ x WT pregnancies, but for females this was also observed for the WT x α/+ cross. AKT signalling is important for placental growth and transport functional capacity [26,83] and recent work has shown that signalling via AKT in the placental LZ can vary in a sex-dependant manner [1,3]. The relevance of our current findings though is unclear, as placental LZ weight was unchanged, or even greater (for males in the α/+ x WT cross) in pregnancies where there was a deficiency in p110α (WT x α/+ or α/+ x WT). However, our data may have implications for previous work showing that WT placentas exposed to different p110α deficiencies vary in their glucose and amino acid transport in vivo [21]. Finally, activation of p38MAPK was decreased in the LZ of WT female fetuses exposed to both littermate and maternal p110α deficiency (i.e. WT x α/+ and α/+ x WT pregnancies compared to WT x WT), but increased specifically in the LZ of WT male fetuses in WT x α/+ compared to α/+ x WT. The significance of sex-specific changes in the WT placenta to littermate and maternal p110α deficiency is unclear.
While our study has multiple strengths, it also has certain limitations. For example, the evaluation of maternal food intake would be very helpful to understand how maternal metabolism and nutrient resources can impact on the changes observed in the placental LZ. Another limitation is that we only examined one gestational age and the changes observed in this study are likely to be a result of placental adaptations occurring earlier. Therefore, future experiments should evaluate additional gestational days to assess the ontogeny of sex-specific adaptations in placenta function. Lastly, our study was only focused on the LZ and we did not study the endocrine junctional zone. Therefore, future work should investigate the changes occurring in this placental region, which is also critical for the success of the pregnancy. Indeed, we have recently shown in mice that small for gestational age fetuses have changes in the function of the junctional zone [84]. Therefore, it is plausible that additional sex-specific adaptations are occurring in this placental region.
To conclude, our data emphasize the significance of the maternal and intrauterine environment in the control of fetal development. Furthermore, modulation of fetal development by the maternal and intrauterine environment is accompanied by changes in placental formation, energetic capacity and abundance of proteins regulating mitochondrial density, lipid metabolism, growth and nutrient handling of female and male fetuses. Our finding may have relevance for understanding the pathways leading to reduced fetal growth in suboptimal maternal environments, as well as for fetal outcomes in the context of multiple gestations/litter bearing species [3].

Supplementary Materials

The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/cells12050797/s1, Figure S1: Placental mitochondrial bioenergetics of WT conceptuses in response to littermate and/or maternal p110α deficiency; Table S1: List of primary antibodies used in this study; Table S2: Litter size and composition.

Author Contributions

Conceptualization, E.S.-P., J.L.-T. and A.N.S.-P.; methodology, J.L.-T. and A.N.S.-P.; software, E.S.-P., D.P.-C. and J.L.-T.; formal analysis, E.S.-P., D.P.-C. and J.L.-T.; investigation, E.S.-P., D.P.-C., J.L.-T. and A.N.S.-P.; resources, J.L.-T. and A.N.S.-P.; data curation, E.S.-P., D.P.-C. and J.L.-T.; writing—original draft preparation, E.S.-P. and D.P.-C.; writing—review and editing, E.S.-P., D.P.-C., J.L.-T. and A.N.S.-P.; visualization, E.S.-P., D.P.-C., J.L.-T. and A.N.S.-P.; supervision, J.L.-T. and A.N.S.-P.; project administration, J.L.-T. and A.N.S.-P.; funding acquisition, J.L.-T. and A.N.S.-P. All authors have read and agreed to the published version of the manuscript.

Funding

E.S.-P. was supported by a Beca-Chile, ANID Postdoctoral (grant number: 74190055). D.P.-C. was supported by Program Institucional de Internacionalização (PRINT) (grant number: 88887.508140/2020-00) and Coordenação de Aperfeiçoamento de Pessoal de Nível Superior—Brasil (CAPES—001). J.L.-T. holds a Sir Henry Wellcome fellowship from the Wellcome Trust UK (grant number: 220456/Z/20/Z). A.N.S.-P. holds an MRC New Investigator Award (grant number: RG93186) and Lister Institute of Preventative Medicine (grant number: RG93692).

Institutional Review Board Statement

All animal work was performed under the U.K. Animals (scientific procedures) Act of 1986, following ethical approval from the University of Cambridge (UK HOL PP6324596).

Informed Consent Statement

Not applicable.

Data Availability Statement

All relevant data are within the paper and available upon reasonable request.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Salazar-Petres, E.; Carvalho, D.P.; Lopez-Tello, J.; Sferruzzi-Perri, A.N. Placental structure, function and mitochondrial phenotype relate to fetal size in each fetal sex in mice. Biol. Reprod. 2022, 106, 1292–1311. [Google Scholar] [CrossRef]
  2. Coan, P.M.; Angiolini, E.; Sandovici, I.; Burton, G.J.; Constância, M.; Fowden, A.L. Adaptations in placental nutrient transfer capacity to meet fetal growth demands depend on placental size in mice. J. Physiol. 2008, 586, 4567–4576. [Google Scholar] [CrossRef] [PubMed]
  3. Sferruzzi-Perri, A.N.; Lopez-Tello, J.; Salazar-Petres, E. Placental adaptations supporting fetal growth during normal and adverse gestational environments. Exp. Physiol. 2022, 108, 1–27. [Google Scholar] [CrossRef] [PubMed]
  4. Burton, G.J.; Fowden, A.L.; Burton, G.J. The placenta: A multifaceted, transient organ. Philos. Trans. R. Soc. B Biol. Sci. 2015, 370, 20140066. [Google Scholar] [CrossRef] [Green Version]
  5. Zhang, S.; Regnault, T.R.H.; Barker, P.L.; Botting, K.J.; McMillen, I.C.; McMillan, C.M.; Roberts, C.T.; Morrison, J.L. Placental adaptations in growth restriction. Nutrients 2015, 7, 360–389. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  6. Sandovici, I.; Hoelle, K.; Angiolini, E.; Constância, M. Placental adaptations to the maternal-fetal environment: Implications for fetal growth and developmental programming. Reprod. Biomed. Online 2012, 25, 68–89. [Google Scholar] [CrossRef] [Green Version]
  7. Napso, T.; Yong, H.E.J.; Lopez-Tello, J.; Sferruzzi-Perri, A.N. The role of placental hormones in mediating maternal adaptations to support pregnancy and lactation. Front. Physiol. 2018, 9, 1–39. [Google Scholar] [CrossRef] [Green Version]
  8. Costa, M.A. The endocrine function of human placenta: An overview. Reprod. Biomed. Online 2015, 32, 14–43. [Google Scholar] [CrossRef] [Green Version]
  9. Stern, C.; Schwarz, S.; Moser, G.; Cvitic, S.; Jantscher-Krenn, E.; Gauster, M.; Hiden, U. Placental endocrine activity: Adaptation and disruption of maternal glucose metabolism in pregnancy and the influence of fetal sex. Int. J. Mol. Sci. 2021, 22, 12722. [Google Scholar] [CrossRef]
  10. Simpson, S.; Smith, L.; Bowe, J. Placental peptides regulating islet adaptation to pregnancy: Clinical potential in gestational diabetes mellitus. Curr. Opin. Pharmacol. 2018, 43, 59–65. [Google Scholar] [CrossRef] [Green Version]
  11. Burton, G.J.; Jauniaux, E.; Charnock-Jones, D.S. The influence of the intrauterine environment on human placental development. Int. J. Dev. Biol. 2010, 54, 303–311. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  12. Dimasuay, K.G.; Boeuf, P.; Powell, T.L.; Jansson, T. Placental responses to changes in the maternal environment determine fetal growth. Front. Physiol. 2016, 7, 1–9. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  13. Woods, L.; Perez-Garcia, V.; Hemberger, M.; Brett, K.E.; Ferraro, Z.M.; Yockell-Lelievre, J.; Gruslin, A.; Adamo, K.B. Maternal–Fetal nutrient transport in pregnancy pathologies: The role of the placenta. Int. J. Mol. Sci. 2014, 15, 16153–16185. [Google Scholar]
  14. Hemberger, M.; Hanna, C.W.; Dean, W. Mechanisms of early placental development in mouse and humans. Nat. Rev. Genet. 2020, 21, 27–43. [Google Scholar] [CrossRef] [PubMed]
  15. Schmidt, A.; Morales-Prieto, D.M.; Pastuschek, J.; Fröhlich, K.; Markert, U.R. Only humans have human placentas: Molecular differences between mice and humans. J. Reprod. Immunol. 2015, 108, 65–71. [Google Scholar] [CrossRef] [PubMed]
  16. Cox, B.; Kotlyar, M.; Evangelou, A.I.; Ignatchenko, V.; Ignatchenko, A.; Whiteley, K.; Jurisica, I.; Adamson, S.L.; Rossant, J.; Kislinger, T. Comparative systems biology of human and mouse as a tool to guide the modeling of human placental pathology. Mol. Syst. Biol. 2009, 5, 1–15. [Google Scholar] [CrossRef]
  17. Coan, P.M.; Vaughan, O.R.; Sekita, Y.; Finn, S.L.; Burton, G.J.; Constancia, M.; Fowden, A.L. Adaptations in placental phenotype support fetal growth during undernutrition of pregnant mice. J. Physiol. 2010, 3, 527–538. [Google Scholar] [CrossRef] [PubMed]
  18. Ganguly, A.; McKnight, R.A.; Raychaudhuri, S.; Shin, B.C.; Ma, Z.; Moley, K.; Devaskar, S.U. Glucose transporter isoform-3 mutations cause early pregnancy loss and fetal growth restriction. Am. J. Physiol.—Endocrinol. Metab. 2007, 292, E1241–E1255. [Google Scholar] [CrossRef] [Green Version]
  19. Constância, M.; Angiolini, E.; Sandovici, I.; Smith, P.; Smith, R.; Kelsey, G.; Dean, W.; Ferguson-smith, A.; Sibley, C.P.; Reik, W.; et al. Adaptation of nutrient supply to fetal demand in the mouse involves interaction between the Igf2 gene and placental transporter systems. Proc. Natl. Acad. Sci. USA 2005, 102, 19219–19224. [Google Scholar] [CrossRef] [Green Version]
  20. Wyrwoll, C.S.; Seckl, J.R.; Holmes, M.C. Altered placental function of 11β-hydroxysteroid dehydrogenase 2 knockout mice. Endocrinology 2009, 150, 1287–1293. [Google Scholar] [CrossRef] [Green Version]
  21. López-Tello, J.; Pérez-García, V.; Khaira, J.; Kusinski, L.C.; Cooper, W.N.; Andreani, A.; Grant, I.; de Liger, E.F.; Lam, B.Y.H.; Hemberger, M.; et al. Fetal and trophoblast PI3K p110α have distinct roles in regulating resource supply to the growing fetus in mice. Elife 2019, 8, 1–25. [Google Scholar] [CrossRef] [PubMed]
  22. James-Allan, L.B.; Teal, S.; Powell, T.L.; Jansson, T. Changes in Placental Nutrient Transporter Protein Expression and Activity Across Gestation in Normal and Obese Women. Reprod. Sci. 2020, 27, 1758–1769. [Google Scholar] [CrossRef]
  23. Borges, M.H.; Pullockaran, J.; Catalano, P.M.; Baumann, M.U.; Zamudio, S.; Illsley, N.P. Human placental GLUT1 glucose transporter expression and the fetal insulin-like growth factor axis in pregnancies complicated by diabetes. Biochim. Biophys. Acta—Mol. Basis Dis. 2019, 1865, 2411–2419. [Google Scholar] [CrossRef] [PubMed]
  24. Sferruzzi-Perri, A.N.; López-Tello, J.; Fowden, A.L.; Constancia, M. Maternal and fetal genomes interplay through phosphoinositol 3-kinase (PI3K)-p110α signaling to modify placental resource allocation. Proc. Natl. Acad. Sci. USA 2016, 113, 11255–11260. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  25. Lu, M.; Sferruzzi-Perri, A.N. Placental mitochondrial function in response to gestational exposures. Placenta 2021, 104, 124–137. [Google Scholar] [CrossRef]
  26. Aye, I.L.M.H.; Aiken, C.E.; Charnock-Jones, D.S.; Smith, G.C.S. Placental energy metabolism in health and disease—Significance of development and implications for preeclampsia. Am. J. Obstet. Gynecol. 2022, 226, S928–S944. [Google Scholar] [CrossRef]
  27. Martinez, F.; Olvera-Sanchez, S.; Esparza-Perusquia, M.; Gomez-Chang, E.; Flores-Herrera, O.; Jornayvaz, F.R.; Shulman, G.I.; Katic, M.; Kennedy, A.R.; Leykin, I.; et al. Multiple functions of syncytiotrophoblast mitochondria. Essays Biochem. 2010, 103, 69–84. [Google Scholar] [CrossRef]
  28. Waker, C.A.; Albers, R.E.; Pye, R.L.; Doliboa, S.R.; Wyatt, C.N.; Brown, T.L.; Mayes, D.A. AMPK Knockdown in Placental Labyrinthine Progenitor Cells Results in Restriction of Critical Energy Resources and Terminal Differentiation Failure. Stem Cells Dev. 2017, 26, 808–817. [Google Scholar] [CrossRef]
  29. Bartho, L.A.; Fisher, J.J.; Walton, S.L.; Perkins, A.V.; Cuffe, J.S.M. The effect of gestational age on mitochondrial properties of the mouse placenta. Reprod. Fertil. 2022, 3, 19–29. [Google Scholar] [CrossRef]
  30. Murray, A.J. Oxygen delivery and fetal-placental growth: Beyond a question of supply and demand? Placenta 2012, 33, e16–e22. [Google Scholar] [CrossRef]
  31. Sferruzzi-Perri, A.N.; Higgins, J.S.; Vaughan, O.R.; Murray, A.J.; Fowden, A.L. Placental mitochondria adapt developmentally and in response to hypoxia to support fetal growth. Proc. Natl. Acad. Sci. USA 2019, 116, 1621–1626. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  32. Holland, O.J.; Hickey, A.J.R.; Alvsaker, A.; Moran, S.; Hedges, C.; Chamley, L.W.; Perkins, A.V. Changes in mitochondrial respiration in the human placenta over gestation. Placenta 2017, 57, 102–112. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  33. Rebelato, H.J.; Esquisatto, M.A.M.; Moraes, C.; Amaral, M.E.C.; Catisti, R. Gestational protein restriction induces alterations in placental morphology and mitochondrial function in rats during late pregnancy. J. Mol. Histol. 2013, 44, 629–637. [Google Scholar] [CrossRef]
  34. Sobrevia, L.; Valero, P.; Grismaldo, A.; Villalobos-Labra, R.; Pardo, F.; Subiabre, M.; Armstrong, G.; Toledo, F.; Vega, S.; Cornejo, M.; et al. Mitochondrial dysfunction in the fetoplacental unit in gestational diabetes mellitus. Biochim. Biophys. Acta—Mol. Basis Dis. 2020, 1866, 165948. [Google Scholar] [CrossRef]
  35. Mayeur, S.; Lancel, S.; Theys, N.; Lukaszewski, M.-A.; Duban-Deweer, S.; Bastide, B.; Hachani, J.; Cecchelli, R.; Breton, C.; Gabory, A.; et al. Maternal calorie restriction modulates placental mitochondrial biogenesis and bioenergetic efficiency: Putative involvement in fetoplacental growth defects in rats. Am. J. Physiol. Endocrinol. Metab. 2013, 304, 14–22. [Google Scholar] [CrossRef]
  36. Yung, H.W.; Colleoni, F.; Dommett, E.; Cindrova-Davies, T.; Kingdom, J.; Murray, A.J.; Burton, G.J. Noncanonical mitochondrial unfolded protein response impairs placental oxidative phosphorylation in early-onset preeclampsia. Proc. Natl. Acad. Sci. USA 2019, 116, 18109–18118. [Google Scholar] [CrossRef] [Green Version]
  37. Mandò, C.; De Palma, C.; Stampalija, T.; Anelli, G.M.; Figus, M.; Novielli, C.; Parisi, F.; Clementi, E.; Ferrazzi, E.; Cetin, I. Placental mitochondrial content and function in intrauterine growth restriction and preeclampsia. Am. J. Physiol.—Endocrinol. Metab. 2014, 306, 404–413. [Google Scholar] [CrossRef] [PubMed]
  38. Holland, O.J.; Cuffe, J.S.M.; Dekker Nitert, M.; Callaway, L.; Kwan Cheung, K.A.; Radenkovic, F.; Perkins, A.V. Placental mitochondrial adaptation in preeclampsia associated with progression to term delivery. Cell Death Dis. 2018, 9, 1150. [Google Scholar] [CrossRef] [Green Version]
  39. Abbade, J.; Klemetti, M.M.; Farrell, A.; Ermini, L.; Gillmore, T.; Sallais, J.; Tagliaferro, A.; Post, M.; Caniggia, I. Increased placental mitochondrial fusion in gestational diabetes mellitus: An adaptive mechanism to optimize feto-placental metabolic homeostasis? BMJ Open Diabetes Res. Care 2020, 8, e000923. [Google Scholar] [CrossRef]
  40. Napso, T.; Hung, Y.P.; Davidge, S.T.; Care, A.S.; Sferruzzi-Perri, A.N. Advanced maternal age compromises fetal growth and induces sex-specific changes in placental phenotype in rats. Sci. Rep. 2019, 9, 1–15. [Google Scholar] [CrossRef] [Green Version]
  41. Napso, T.; Lean, S.C.; Lu, M.; Mort, E.J.; Desforges, M.; Moghimi, A.; Bartels, B.; El-Bacha, T.; Fowden, A.L.; Camm, E.J.; et al. Diet-induced maternal obesity impacts feto-placental growth and induces sex-specific alterations in placental morphology, mitochondrial bioenergetics, dynamics, lipid metabolism and oxidative stress in mice. Acta Physiol. 2022, 234, e13795. [Google Scholar] [CrossRef] [PubMed]
  42. Engelman, J.A.; Luo, J.; Cantley, L.C. The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism. Nat. Rev. Genet. 2006, 7, 606–619. [Google Scholar] [CrossRef] [PubMed]
  43. Bettedi, L.; Yan, A.; Schuster, E.; Alic, N.; Foukas, L.C. Increased mitochondrial and lipid metabolism is a conserved effect of Insulin/PI3K pathway downregulation in adipose tissue. Sci. Rep. 2020, 10, 3418. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  44. Gao, M.; Wang, J.; Wang, W.; Liu, J.; Wong, C.W. Phosphatidylinositol 3-kinase affects mitochondrial function in part through inducing peroxisome proliferator-activated receptor γ coactivator-1β expression. Br. J. Pharmacol. 2011, 162, 1000–1008. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  45. Yu, J.S.L.; Cui, W. Proliferation, survival and metabolism: The role of PI3K/AKT/ mTOR signalling in pluripotency and cell fate determination. Development 2016, 143, 3050–3060. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  46. Tu-Sekine, B.; Kim, S.F. The Inositol Phosphate System—A Coordinator of Metabolic Adaptability. Int. J. Mol. Sci. 2022, 23, 6747. [Google Scholar] [CrossRef]
  47. Cardoso, S.; López, I.P.; Piñeiro-Hermida, S.; Pichel, J.G.; Moreira, P.I. Igf1r deficiency modulates brain signaling pathways and disturbs mitochondria and redox homeostasis. Biomedicines 2021, 9, 158. [Google Scholar] [CrossRef]
  48. Zhang, D.; Wei, Y.; Huang, Q.; Chen, Y.; Zeng, K.; Yang, W.; Chen, J.; Chen, J. Important Hormones Regulating Lipid Metabolism. Molecules 2022, 27, 7052. [Google Scholar] [CrossRef]
  49. Foukas, L.C.; Claret, M.; Pearce, W.; Okkenhaug, K.; Meek, S.; Peskett, E.; Sancho, S.; Smith, A.J.H.; Withers, D.J.; Vanhaesebroeck, B. Critical role for the p110 a phosphoinositide-3-OH kinase in growth and metabolic regulation. Nature 2006, 441, 3–7. [Google Scholar] [CrossRef]
  50. Knight, Z.A.; Gonzalez, B.; Feldman, M.E.; Zunder, E.R.; Goldenberg, D.D.; Williams, O.; Loewith, R.; Stokoe, D.; Balla, A.; Toth, B.; et al. A Pharmacological Map of the PI3-K Family Defines a Role for p110 a in Insulin Signaling. Cell 2006, 125, 733–747. [Google Scholar] [CrossRef] [Green Version]
  51. Taniguchi, C.M.; Kondo, T.; Sajan, M.; Luo, J.; Bronson, R.; Asano, T.; Farese, R.; Cantley, L.C.; Kahn, C.R. Divergent regulation of hepatic glucose and lipid metabolism by phosphoinositide 3-kinase via Akt and PKC l/z. Cell Metab. 2006, 3, 343–353. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  52. Sopasakis, V.R.; Liu, P.; Suzuki, R.; Kondo, T.; Winnay, J.; Tran, T.T.; Asano, T.; Smyth, G.; Sajan, M.P.; Farese, R.V.; et al. Short Article Specific Roles of the p110 a Isoform of Phosphatidylinsositol 3-Kinase in Hepatic Insulin Signaling and Metabolic Regulation. Cell Metab. 2010, 11, 220–230. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  53. Pérez-García, V.; Redondo-Muñoz, J.; Kumar, A.; Carrera, A.C. Cell activation-induced phosphoinositide 3-kinase alpha/beta dimerization regulates PTEN activity. Mol. Cell Biol. 2014, 34, 3359–3373. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  54. Lopez-Tello, J.; Salazar-Petres, E.; Webb, L.; Fowden, A.L.; Sferruzzi-Perri, A.N. Ablation of PI3K-p110alpha Impairs Maternal Metabolic Adaptations to Pregnancy. Front. Cell Dev. Biol. 2022, 10, 928210. [Google Scholar] [CrossRef]
  55. Makarova, E.N.; Kochubei, E.D.; Bazhan, N.M. Regulation of food consumption during pregnancy and lactation in mice. Neurosci. Behav. Physiol. 2010, 40, 263–267. [Google Scholar] [CrossRef]
  56. Pereira-Carvalho, D.; Salazar-Petres, E.; Lopez-Tello, J.; Sferruzzi-Perri, A.N. Maternal and Fetal PI3K-p110α Deficiency Induces Sex-Specific Changes in Conceptus Growth and Placental Mitochondrial Bioenergetic Reserve in Mice. Vet. Sci. 2022, 9, 501. [Google Scholar] [CrossRef]
  57. Djafarzadeh, S.; Jakob, S.M. High-resolution respirometry to assess mitochondrial function in permeabilized and intact cells. J. Vis. Exp. 2017, 2017, 1–11. [Google Scholar]
  58. Romero-Calvo, I.; Ocón, B.; Martínez-Moya, P.; Suárez, M.D.; Zarzuelo, A.; Martínez-Augustin, O.; de Medina, F.S. Reversible Ponceau staining as a loading control alternative to actin in Western blots. Anal. Biochem. 2010, 401, 318–320. [Google Scholar] [CrossRef]
  59. Tunster, S.J.; Creeth, H.D.J.; John, R.M. The imprinted Phlda2 gene modulates a major endocrine compartment of the placenta to regulate placental demands for maternal resources. Dev. Biol. 2016, 409, 251–260. [Google Scholar] [CrossRef] [Green Version]
  60. Kalisch-Smith, J.I.; Simmons, D.G.; Dickinson, H.; Moritz, K.M. Review: Sexual dimorphism in the formation, function and adaptation of the placenta. Placenta 2017, 54, 10–16. [Google Scholar] [CrossRef]
  61. Eriksson, J.G.; Kajantie, E.; Osmond, C.; Thornburg, K.; Barker, D.J.P. Boys live dangerously in the womb. Am. J. Hum. Biol. Counc. 2010, 22, 330–335. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  62. Bartels, H.C.; Geraghty, A.A.; O’Brien, E.C.; Kranidi, A.; Mehegan, J.; Yelverton, C.; McDonnell, C.M.; McAuliffe, F.M. Fetal Growth Trajectories and Their Association with Maternal, Cord Blood, and 5-year Child Adipokines. J. Nutr. Metab. 2020, 2020, 4861523. [Google Scholar] [CrossRef] [PubMed]
  63. Broere-Brown, Z.A.; Baan, E.; Schalekamp-Timmermans, S.; Verburg, B.O.; Jaddoe, V.W.V.; Steegers, E.A.P. Sex-specific differences in fetal and infant growth patterns: A prospective population-based cohort study. Biol. Sex Differ. 2016, 7, 1–9. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  64. Aykroyd, B.R.L.; Tunster, S.J.; Sferruzzi-Perri, A.N. Loss of imprinting of the Igf2-H19 ICR1 enhances placental endocrine capacity via sex-specific alterations in signalling pathways in the mouse. Development 2022, 149, dev199811. [Google Scholar] [CrossRef] [PubMed]
  65. Aykroyd, B.R.L.; Tunster, S.J.; Sferruzzi-Perri, A.N. Igf2 deletion alters mouse placenta endocrine capacity in a sexually dimorphic manner. J. Endocrinol. 2020, 246, 93–108. [Google Scholar] [CrossRef] [PubMed]
  66. Sferruzzi-Perri, A.N.; Sandovici, I.; Constancia, M.; Fowden, A.L. Placental phenotype and the insulin-like growth factors: Resource allocation to fetal growth. J. Physiol. 2017, 15, 5057–5093. [Google Scholar] [CrossRef] [Green Version]
  67. Wen, Q.; Cheng, C.Y.; Liu, Y.X. Development, function and fate of fetal Leydig cells. Semin. Cell Dev. Biol. 2016, 59, 89–98. [Google Scholar] [CrossRef] [Green Version]
  68. Biason-Lauber, A.; Chaboissier, M.C. Ovarian development and disease: The known and the unexpected. Semin. Cell Dev. Biol. 2015, 45, 59–67. [Google Scholar] [CrossRef]
  69. Hebert, J.F.; Myatt, L. Placental mitochondrial dysfunction with metabolic diseases: Therapeutic approaches. Biochim. Biophys. Acta—Mol. Basis Dis. 2021, 1867, 165967. [Google Scholar] [CrossRef]
  70. Muralimanoharan, S.; Guo, C.; Myatt, L.; Maloyan, A. Sexual dimorphism in MIR-210 expression and mitochondrial dysfunction in the placenta with maternal obesity. Int. J. Obes. 2015, 39, 1274–1281. [Google Scholar] [CrossRef] [Green Version]
  71. Mishra, J.S.; Blesson, C.S.; Kumar, S. Testosterone decreases placental mitochondrial content and cellular bioenergetics. Biology 2020, 9, 176. [Google Scholar] [CrossRef] [PubMed]
  72. Cuffe, J.S.M.; Dickinson, H.; Simmons, D.G.; Moritz, K.M. Sex specific changes in placental growth and MAPK following short term maternal dexamethasone exposure in the mouse. Placenta 2011, 32, 981–989. [Google Scholar] [CrossRef] [PubMed]
  73. Evans, L.S.; Myatt, L. Sexual dimorphism in the effect of maternal obesity on antioxidant defense mechanisms in the human placenta. Placenta 2017, 51, 64–69. [Google Scholar] [CrossRef] [Green Version]
  74. Jiang, S.; Teague, A.M.; Tryggestad, J.B.; Aston, C.E.; Lyons, T.; Chernausek, S.D. Effects of maternal diabetes and fetal sex on human placenta mitochondrial biogenesis. Placenta 2017, 57, 26–32. [Google Scholar] [CrossRef]
  75. Ganguly, E.; Kirschenman, R.; Spaans, F.; Holody, C.D.; Phillips, T.E.J.; Case, C.P.; Murphy, M.P.; Lemieux, H.; Davidge, S.T. Nanoparticle-encapsulated antioxidant improves placental mitochondrial function in a sexually dimorphic manner in a rat model of prenatal hypoxia. FASEB J. 2021, 35, 1–16. [Google Scholar] [CrossRef] [PubMed]
  76. Vangrieken, P.; Al-Nasiry, S.; Bast, A.; Leermakers, P.A.; Tulen, C.B.M.; Schiffers, P.M.H.; van Schooten, F.J.; Remels, A.H.V. Placental Mitochondrial Abnormalities in Preeclampsia. Reprod. Sci. 2021, 28, 2186–2199. [Google Scholar] [CrossRef]
  77. Fisher, J.J.; Bartho, L.A.; Perkins, A.V.; Holland, O.J. Placental mitochondria and reactive oxygen species in the physiology and pathophysiology of pregnancy. Clin. Exp. Pharmacol. Physiol. 2020, 47, 176–184. [Google Scholar] [CrossRef]
  78. Hastie, R.; Lappas, M. The effect of pre-existing maternal obesity and diabetes on placental mitochondrial content and electron transport chain activity. Placenta 2014, 35, 673–683. [Google Scholar] [CrossRef]
  79. Muralimanoharan, S.; Maloyan, A.; Myatt, L. Mitochondrial function and glucose metabolism in the placenta with gestational diabetes mellitus: Role of miR-143. Clin. Sci. 2016, 130, 931–941. [Google Scholar] [CrossRef] [Green Version]
  80. Luo, Z.; Luo, W.; Li, S.; Zhao, S.; Sho, T.; Xu, X.; Zhang, J.; Xu, W.; Xu, J. Reactive oxygen species mediated placental oxidative stress, mitochondrial content, and cell cycle progression through mitogen-activated protein kinases in intrauterine growth restricted pigs. Reprod. Biol. 2018, 18, 422–431. [Google Scholar] [CrossRef]
  81. Ramírez-Emiliano, J.; Fajardo-Araujo, M.E.; Zúñiga-Trujillo, I.; Pérez-Vázquez, V.; Sandoval-Salazar, C.; Órnelas-Vázquez, J.K. Mitochondrial content, oxidative, and nitrosative stress in human full-term placentas with gestational diabetes mellitus. Reprod. Biol. Endocrinol. 2017, 15, 1–8. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  82. Marín, R.; Chiarello, D.I.; Abad, C.; Rojas, D.; Toledo, F.; Sobrevia, L. Oxidative stress and mitochondrial dysfunction in early-onset and late-onset preeclampsia. Biochim. Biophys. Acta—Mol. Basis Dis. 2020, 1866, 165961. [Google Scholar] [CrossRef] [PubMed]
  83. Burton, G.J.; Jauniaux, E. Expert Reviews Pathophysiology of placental-derived fetal growth restriction. Am. J. Obstet. Gynecol. 2018, 218, S745–S761. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  84. Lopez-Tello, J.; Sferruzzi-Perri, A.N. Characterization of placental endocrine function and fetal brain development in a mouse model of small for gestational age. Front. Endocrinol. 2023, 14, 1–11. [Google Scholar] [CrossRef] [PubMed]
Cells 12 00797 g001 550
Figure 1. Illustrative figure representing the crosses used in the study. WT = wild-type; α/+ = Heterozygous Pik3ca-D933A mice; F = female fetus; M = male fetus.
Figure 1. Illustrative figure representing the crosses used in the study. WT = wild-type; α/+ = Heterozygous Pik3ca-D933A mice; F = female fetus; M = male fetus.
Cells 12 00797 g001
Cells 12 00797 g002 550
Figure 2. Fetal and placental growth of WT conceptuses in response to littermate and/or maternal p110α deficiency. Fetal weight (A), placenta weight (B), LZ weight (C), and fetal weight/LZ weight (D) in females and males on day 18 of pregnancy. Data are from WT fetuses generated by WT x WT, WT x α/+, and α/+ x WT parental crosses (n = 1–2 fetuses/sex/dam with 5–12 dams/group) and are displayed as individual data points with mean ± S.E.M. Data were analysed by one-way ANOVA with Tukey post hoc pairwise comparisons (* p < 0.05, ** p < 0.01, *** p < 0.001, pairwise comparison). LZ: labyrinthine zone.
Figure 2. Fetal and placental growth of WT conceptuses in response to littermate and/or maternal p110α deficiency. Fetal weight (A), placenta weight (B), LZ weight (C), and fetal weight/LZ weight (D) in females and males on day 18 of pregnancy. Data are from WT fetuses generated by WT x WT, WT x α/+, and α/+ x WT parental crosses (n = 1–2 fetuses/sex/dam with 5–12 dams/group) and are displayed as individual data points with mean ± S.E.M. Data were analysed by one-way ANOVA with Tukey post hoc pairwise comparisons (* p < 0.05, ** p < 0.01, *** p < 0.001, pairwise comparison). LZ: labyrinthine zone.
Cells 12 00797 g002
Cells 12 00797 g003 550
Figure 3. Placental mitochondrial bioenergetics of WT conceptuses in response to littermate and/or maternal p110α deficiency. Oxygen consumption in the placental LZ associated with CILEAK (A), CIOXPHOS (B), CI + CIIOXPHOS (C), CII (D), total ETS (E), reserve capacity (F), CILEAK/total ETS (G), and CIOXPHOS/total ETS (H) for females and males on day 18 of pregnancy. Data are from WT fetuses generated by WT x WT, WT x α/+, and α/+ x WT parental crosses (n = 1–2 fetuses/sex/dam with 5–12 dams/group) and are displayed as individual data points with mean ± S.E.M. Data were analysed by one-way ANOVA with Tukey post hoc pairwise comparisons (* p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001, pairwise comparison).
Figure 3. Placental mitochondrial bioenergetics of WT conceptuses in response to littermate and/or maternal p110α deficiency. Oxygen consumption in the placental LZ associated with CILEAK (A), CIOXPHOS (B), CI + CIIOXPHOS (C), CII (D), total ETS (E), reserve capacity (F), CILEAK/total ETS (G), and CIOXPHOS/total ETS (H) for females and males on day 18 of pregnancy. Data are from WT fetuses generated by WT x WT, WT x α/+, and α/+ x WT parental crosses (n = 1–2 fetuses/sex/dam with 5–12 dams/group) and are displayed as individual data points with mean ± S.E.M. Data were analysed by one-way ANOVA with Tukey post hoc pairwise comparisons (* p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001, pairwise comparison).
Cells 12 00797 g003
Cells 12 00797 g004 550
Figure 4. Protein abundance of mitochondrial complexes and key mitochondrial regulatory proteins in placental labyrinth of WT conceptuses in response to littermate and/or maternal p110α deficiency. Relative protein abundance of mitochondrial complexes in females (A) and males (B), as well as citrate synthase (C), PGC1α (D), PPARγ (E), and UCP2 (F) in females and males. Representative images from each antibody and Ponceau staining are included. Data are from 1 WT fetus per dam generated by WT x WT (n = 4), WT x α/+ (n = 5), and α/+ x WT (n = 5) parental crosses and are displayed as individual data points with mean ± S.E.M. Data were analysed by one-way ANOVA and Tukey post hoc pairwise comparisons (* p < 0.05, ** p < 0.01, *** p < 0.001, pairwise comparison).
Figure 4. Protein abundance of mitochondrial complexes and key mitochondrial regulatory proteins in placental labyrinth of WT conceptuses in response to littermate and/or maternal p110α deficiency. Relative protein abundance of mitochondrial complexes in females (A) and males (B), as well as citrate synthase (C), PGC1α (D), PPARγ (E), and UCP2 (F) in females and males. Representative images from each antibody and Ponceau staining are included. Data are from 1 WT fetus per dam generated by WT x WT (n = 4), WT x α/+ (n = 5), and α/+ x WT (n = 5) parental crosses and are displayed as individual data points with mean ± S.E.M. Data were analysed by one-way ANOVA and Tukey post hoc pairwise comparisons (* p < 0.05, ** p < 0.01, *** p < 0.001, pairwise comparison).
Cells 12 00797 g004
Cells 12 00797 g005 550
Figure 5. Abundance of growth and metabolic signalling proteins in placental labyrinth of WT conceptuses in response to littermate and/or maternal p110α deficiency. Female (A) and male (B) representative images from each antibody immunodetection and Ponceau staining for phosphorylated and total AKT, AMPKα, MAPK 44/42, and P38 MAPK. Total AKT, AMPKα, MAPK 44/42, and P38 MAPK protein levels in females and males (C), and AKT, AMPKα, MAPK 44/42, and P38 MAPK phosphorylation levels as a ratio to total protein in females and males (D). Data are from 1 WT fetus per dam generated by WT x WT (n = 4), WT x α/+ (n = 5), and α/+ x WT (n = 5) parental crosses and are displayed as individual data points with mean ± S.E.M. Data were analysed by one-way ANOVA with Tukey post hoc pairwise comparisons (* p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001, pairwise comparison). p = phosphorylated, t = total.
Figure 5. Abundance of growth and metabolic signalling proteins in placental labyrinth of WT conceptuses in response to littermate and/or maternal p110α deficiency. Female (A) and male (B) representative images from each antibody immunodetection and Ponceau staining for phosphorylated and total AKT, AMPKα, MAPK 44/42, and P38 MAPK. Total AKT, AMPKα, MAPK 44/42, and P38 MAPK protein levels in females and males (C), and AKT, AMPKα, MAPK 44/42, and P38 MAPK phosphorylation levels as a ratio to total protein in females and males (D). Data are from 1 WT fetus per dam generated by WT x WT (n = 4), WT x α/+ (n = 5), and α/+ x WT (n = 5) parental crosses and are displayed as individual data points with mean ± S.E.M. Data were analysed by one-way ANOVA with Tukey post hoc pairwise comparisons (* p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001, pairwise comparison). p = phosphorylated, t = total.
Cells 12 00797 g005
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Salazar-Petres, E.; Pereira-Carvalho, D.; Lopez-Tello, J.; Sferruzzi-Perri, A.N. Maternal and Intrauterine Influences on Feto-Placental Growth Are Accompanied by Sexually Dimorphic Changes in Placental Mitochondrial Respiration, and Metabolic Signalling Pathways. Cells 2023, 12, 797. https://doi.org/10.3390/cells12050797

AMA Style

Salazar-Petres E, Pereira-Carvalho D, Lopez-Tello J, Sferruzzi-Perri AN. Maternal and Intrauterine Influences on Feto-Placental Growth Are Accompanied by Sexually Dimorphic Changes in Placental Mitochondrial Respiration, and Metabolic Signalling Pathways. Cells. 2023; 12(5):797. https://doi.org/10.3390/cells12050797

Chicago/Turabian Style

Salazar-Petres, Esteban, Daniela Pereira-Carvalho, Jorge Lopez-Tello, and Amanda N. Sferruzzi-Perri. 2023. "Maternal and Intrauterine Influences on Feto-Placental Growth Are Accompanied by Sexually Dimorphic Changes in Placental Mitochondrial Respiration, and Metabolic Signalling Pathways" Cells 12, no. 5: 797. https://doi.org/10.3390/cells12050797

APA Style

Salazar-Petres, E., Pereira-Carvalho, D., Lopez-Tello, J., & Sferruzzi-Perri, A. N. (2023). Maternal and Intrauterine Influences on Feto-Placental Growth Are Accompanied by Sexually Dimorphic Changes in Placental Mitochondrial Respiration, and Metabolic Signalling Pathways. Cells, 12(5), 797. https://doi.org/10.3390/cells12050797

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop